2017
DOI: 10.1097/md.0000000000007600
|View full text |Cite
|
Sign up to set email alerts
|

Microvessel density as a prognostic factor in esophageal squamous cell cancer patients

Abstract: Background:To date, literature has emerged that shows contradictory results about the prognostic role of microvessel density (MVD) in esophageal squamous cell cancer (ESCC). The aim of the study set out to evaluate the correlation between MVD and the prognosis of ESCC.Methods:Identified publications from various databases were obtained and reviewed. A meta-analysis was performed to evaluate the prognostic role of MVD among ESCC patients.Results:A total of 11 eligible studies containing 891 ESCC cases were incl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 48 publications
5
9
0
Order By: Relevance
“…The Alder grades are mainly concentrated on the blood flow signals, which to some extent can reflect the proliferation of vessels and the characteristics of microvessel density around the cervical cancer. Previous studies [32][33][34] have reported that the blood signals may predict the ability of tumor invasion and metastasis to a certain extent, which is consistent with the results of our study.…”
Section: Plos Onesupporting
confidence: 93%
“…The Alder grades are mainly concentrated on the blood flow signals, which to some extent can reflect the proliferation of vessels and the characteristics of microvessel density around the cervical cancer. Previous studies [32][33][34] have reported that the blood signals may predict the ability of tumor invasion and metastasis to a certain extent, which is consistent with the results of our study.…”
Section: Plos Onesupporting
confidence: 93%
“…During the last 20 years, different studies recognised 'high' MVD a poor prognostic factor for cancer patients, 2729 including women affected by OC. 30 Different biomarkers have been adopted to assess MVD in OC, including Von Willebrand Factor, CD105, CD34 and CD31, being CD34 the most used MVD detector and the biomarker associated with the poorest HR for OS (HR: 1.67, CI 95%: 1.36–2.35) compared to other MVD detectors (HR: 1.32, CI 95%: 0.82–1.82).…”
Section: Discussionmentioning
confidence: 99%
“…[7] Currently, antibodies for staining endothelial cells of microvessel mainly include those against platelet/endothelial cell adhesion molecule CD31, pan-endothelial marker CD34, homodimeric transmembrane protein CD105, and von Willebrand Factor. [8] It has been proved that MVD is correlated with the prognosis in patients with various malignancies, including breast cancer, [9] colorectal cancer, [10] non-small cell lung cancer, [11] and so on.…”
Section: Introductionmentioning
confidence: 99%